The prognostic value of maturation-associated phenotypic abnormalities in myelodysplastic syndromes

被引:12
|
作者
Lorand-Metze, I. [1 ]
Califani, S. M. V. [1 ]
Ribeiro, E. [1 ]
Lima, C. S. P. [1 ]
Metze, K. [1 ]
机构
[1] Univ Estadual Campinas, Fac Med, BR-13081970 Campinas, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
myelodysplastic syndromes; cell maturation; phenotypic aberrations; flow cytometry; prognosis;
D O I
10.1016/j.leukres.2007.06.014
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Several phenotypic abnormalities of bone marrow (BM) hemopoietic precursors have been associated with disease progression in myelodysplastic syndromes (MDS). We analyzed the influence on overall survival of the expression of lineage and maturation-associated antigens of BM hemopoietic cells quantified in a previous study. In the univariate Cox regression the peripheral platelet count was a significant favourable factor for overall survival. Unfavorable prognostic factors were: WPSS, increase in BM CD34+ cells, increased mean fluorescence intensity (MFI) of CD13 on myelocytes, metamyelocytes and mature neutrophils as well as increased CD45 of myelocytes and mature neutrophils. In a model containing platelet count, WPSS and MFI of CD45 and CD13 on mature neutrophils, only hyperexpression of CD13 and degree of thrombocytopenia were independent risk factors. Therefore, phenotypic features that can also be obtained from PB might be useful for predicting Survival in MDS. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:211 / 213
页数:3
相关论文
共 50 条
  • [1] Maturation-associated immunophenotypic abnormalities in bone marrow B-lymphocytes in myelodysplastic syndromes
    Ribeiro, E
    Sudón, SM
    de Santiago, M
    Lima, CSP
    Metze, K
    Giralt, M
    Saad, STO
    de Matos, AO
    Lorand-Metze, I
    LEUKEMIA RESEARCH, 2006, 30 (01) : 9 - 16
  • [2] Cytogenetics and its prognostic value in myelodysplastic syndromes
    Verhoef, GEG
    Boogaerts, MA
    ACTA HAEMATOLOGICA, 1996, 95 (02) : 95 - 101
  • [3] Prognostic value of circulating CD34+ cells in myelodysplastic syndromes
    Cesana, Clara
    Klersy, Catherine
    Brando, Bruno
    Nosari, Annamaria
    Scarpati, Barbara
    Scampini, Linda
    Molteni, Alfredo
    Nador, Guido
    Santoleri, Luca
    Formenti, Marta
    Valentini, Marina
    Mazzone, Antonino
    Morra, Enrica
    Cairoli, Roberto
    LEUKEMIA RESEARCH, 2008, 32 (11) : 1715 - 1723
  • [4] Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes
    Wimazal, F
    Sperr, WR
    Kundi, M
    Meidlinger, P
    Fonatsch, C
    Jordan, JH
    Thalhammer-Scherrer, R
    Schwarzinger, I
    Geissler, K
    Lechner, K
    Valent, P
    LEUKEMIA RESEARCH, 2001, 25 (04) : 287 - 294
  • [5] The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes
    Duong, Vu H.
    Padron, Eric
    Al Ali, Najla H.
    Lancet, Jeffrey E.
    Hall, Jeff
    Kwok, Brian
    Zhang, Ling
    Epling-Burnette, Pearlie K.
    List, Alan F.
    Komrokji, Rami S.
    ANNALS OF HEMATOLOGY, 2018, 97 (02) : 247 - 254
  • [6] The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes
    Vu H. Duong
    Eric Padron
    Najla H. Al Ali
    Jeffrey E. Lancet
    Jeff Hall
    Brian Kwok
    Ling Zhang
    Pearlie K. Epling-Burnette
    Alan F. List
    Rami S. Komrokji
    Annals of Hematology, 2018, 97 : 247 - 254
  • [7] PROGNOSTIC FACTORS IN MYELODYSPLASTIC SYNDROMES
    SANZ, GF
    SANZ, MA
    LEUKEMIA RESEARCH, 1992, 16 (01) : 77 - 86
  • [8] Surface marker abnormalities in myelodysplastic syndromes
    Elghetany, MT
    HAEMATOLOGICA, 1998, 83 (12) : 1104 - 1115
  • [9] Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes
    Solé, F
    Espinet, B
    Sanz, GF
    Cervera, J
    Calasanz, MJ
    Luño, E
    Prieto, F
    Granada, I
    Hernández, JM
    Cigudosa, JC
    Diez, JL
    Bureo, E
    Marqués, ML
    Arranz, E
    Ríos, R
    Climent, JAM
    Vallespí, T
    Florensa, L
    Woessner, S
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (02) : 346 - 356
  • [10] Prognostic molecular markers in myelodysplastic syndromes
    Neukirchen, Judith
    Haas, Rainer
    Germing, Ulrich
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (05) : 563 - 575